Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety assessment of dried allogeneic cultured epidermis for skin defects
jRCTs052190079Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Apr 2020
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of Allo-JaCE03 in burn injury, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Safety. Started Apr 2020; status: completed.
02
Drugs
Allo-JaCE03
03
Conditions
burn injury
Beyond the preview
Go deeper on jRCTs052190079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs052190079.